MedPath

Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia

Phase 4
Conditions
Cholecystitis
Interventions
Registration Number
NCT02493231
Lead Sponsor
Hallym University Kangnam Sacred Heart Hospital
Brief Summary

Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam,which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • patient who scheduled laparoscopic cholecystectomy under general anesthesia
  • American Society of Anesthesiologist(ASA) class I or II
  • adult patient (age 20 - 65)
Exclusion Criteria
  • patient who has liver disease
  • patient who has kidney disease
  • patient who has diabetes mellitus(DM) or heart disease
  • patient who takes opioid or beta-blocker
  • patient who has airway disease
  • patient who has allergy with the drug

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
KetamineKetamineIt is infused during operation. A induction dose is 0.3 mg/Kg. A maintenance dose is 3 mcg/kg/hr
SalineSalineIt is infused during operation. A induction volume is 3mL A maintenance dose is 10mL/hr
NefopamNefopamThe generic name is 'ACUPAN'. It is infused during operation. A induction dose is 0.3mg/Kg. A maintenance dose is 65 mcg/kg/hr
Primary Outcome Measures
NameTimeMethod
duration of analgesic freeDuring 1 hour at PACU
analgesic requirementDuring 1 hour at PACU
Secondary Outcome Measures
NameTimeMethod
analgesic requirementDuring 8 hours after arriving at ward
Pain on the VAS scaleDuring 1 hour at PACU

Trial Locations

Locations (1)

Hallym University Kangnam Sacred Heart Hospita

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath